✦ LIBER ✦

Does the Pro-Hypertensive Effect of Cyclooxygenase-2 Inhibitors Account for the Increased Risk in Cardiovascular Disease?

✍ Scribed by Franz H. Messerli; Tina Sichrovsky

Book ID: 113442208
Publisher: Elsevier Science
Year: 2005
Tongue: English
Weight: 45 KB
Volume: 96
Category: Article
ISSN: 0002-9149
DOI: 10.1016/j.amjcard.2005.05.038

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The cyclooxygenase-2 specific inhibitor

The cyclooxygenase-2 specific inhibitor valdecoxib is not associated with an increased risk of cardiovascular thrombotic events in arthritis patients

✍ William B. White; Kenneth M. Verburg; Andrew Whelton 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 164 KB

Does accounting for gene-environment (G×

Does accounting for gene-environment (G×E) interaction increase the power to detect the effect of a gene in a multifactorial disease?

✍ Hana Selinger-Leneman; Emmanuelle Genin; Jill M. Norris; Myriam Khlat 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 125 KB 👁 1 views

## Abstract Despite tremendous efforts, few genes involved in the susceptibility for complex disorders have been identified. One explanation is that these disorders are a result of an interaction between genes and environment, and under such conditions, it may be difficult to measure the true genet

S5-2 Hydrogen sulfide accounts for the p

S5-2 Hydrogen sulfide accounts for the peripheral vascular effects of sulfhydrylated ace inhibitors beyond ace inhibition: A proof of concept of the role of H2S in cardiovascular?

✍ Cirino, Giuseppe 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 39 KB

Serum Lp(α), insulin resistance, metabol

Serum Lp(α), insulin resistance, metabolic risk factors for cardiovascular disease, and the long term effects of bezafibrate in type 2 diabetes

✍ R.S. Elkeles; J.R. Diamond; G. Salerno; C. Hughes; W. Richmond; V. Anyaoku 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 151 KB